Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
1(8%)
Results Posted
22%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
2
17%
Ph phase_2
1
8%
Ph not_applicable
9
75%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(9)
Terminated(2)

Detailed Status

Completed9
Terminated1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (16.7%)
Phase 21 (8.3%)
N/A9 (75.0%)

Trials by Status

terminated18%
recruiting18%
withdrawn18%
completed975%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12